221 related articles for article (PubMed ID: 23887803)
1. Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD.
Gammons MV; Fedorov O; Ivison D; Du C; Clark T; Hopkins C; Hagiwara M; Dick AD; Cox R; Harper SJ; Hancox JC; Knapp S; Bates DO
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6052-62. PubMed ID: 23887803
[TBL] [Abstract][Full Text] [Related]
2. Excessive retinol intake exacerbates choroidal neovascularization through upregulated vascular endothelial growth factor in retinal pigment epithelium in mice.
Tan X; Takahashi H; Nishida J; Aoki A; Inoue T; Yanagi Y
Exp Eye Res; 2015 Feb; 131():77-83. PubMed ID: 25576666
[TBL] [Abstract][Full Text] [Related]
3. Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo.
Pons M; Marin-Castaño ME
PLoS One; 2011 Feb; 6(2):e16722. PubMed ID: 21386905
[TBL] [Abstract][Full Text] [Related]
4. SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform.
Hatcher JM; Wu G; Zeng C; Zhu J; Meng F; Patel S; Wang W; Ficarro SB; Leggett AL; Powell CE; Marto JA; Zhang K; Ki Ngo JC; Fu XD; Zhang T; Gray NS
Cell Chem Biol; 2018 Apr; 25(4):460-470.e6. PubMed ID: 29478907
[TBL] [Abstract][Full Text] [Related]
5. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.
Lavine JA; Farnoodian M; Wang S; Darjatmoko SR; Wright LS; Gamm DM; Ip MS; Sorenson CM; Sheibani N
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):299-308. PubMed ID: 28114591
[TBL] [Abstract][Full Text] [Related]
6. Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.
Batson J; Toop HD; Redondo C; Babaei-Jadidi R; Chaikuad A; Wearmouth SF; Gibbons B; Allen C; Tallant C; Zhang J; Du C; Hancox JC; Hawtrey T; Da Rocha J; Griffith R; Knapp S; Bates DO; Morris JC
ACS Chem Biol; 2017 Mar; 12(3):825-832. PubMed ID: 28135068
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TBK1 reduces choroidal neovascularization in vitro and in vivo.
Cui K; Zhang S; Liu X; Yan Z; Huang L; Yang X; Zhu R; Sang A
Biochem Biophys Res Commun; 2018 Sep; 503(1):202-208. PubMed ID: 29864423
[TBL] [Abstract][Full Text] [Related]
8. Effects of dioxin on vascular endothelial growth factor (VEGF) production in the retina associated with choroidal neovascularization.
Takeuchi A; Takeuchi M; Oikawa K; Sonoda KH; Usui Y; Okunuki Y; Takeda A; Oshima Y; Yoshida K; Usui M; Goto H; Kuroda M
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3410-6. PubMed ID: 19182260
[TBL] [Abstract][Full Text] [Related]
9. Thy-1 Regulates VEGF-Mediated Choroidal Endothelial Cell Activation and Migration: Implications in Neovascular Age-Related Macular Degeneration.
Wang H; Han X; Kunz E; Hartnett ME
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5525-5534. PubMed ID: 27768790
[TBL] [Abstract][Full Text] [Related]
10. Intravenous injection of l-aspartic acid β-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation.
Wu M; Liu Y; Zhang H; Lian M; Chen J; Jiang H; Xu Y; Shan G; Wu S
Exp Eye Res; 2019 May; 182():93-100. PubMed ID: 30917905
[TBL] [Abstract][Full Text] [Related]
11. Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis.
Stahl A; Paschek L; Martin G; Feltgen N; Hansen LL; Agostini HT
Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):767-73. PubMed ID: 19247683
[TBL] [Abstract][Full Text] [Related]
12. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.
Nowak DG; Amin EM; Rennel ES; Hoareau-Aveilla C; Gammons M; Damodoran G; Hagiwara M; Harper SJ; Woolard J; Ladomery MR; Bates DO
J Biol Chem; 2010 Feb; 285(8):5532-40. PubMed ID: 19906640
[TBL] [Abstract][Full Text] [Related]
13. Decorin inhibits angiogenic potential of choroid-retinal endothelial cells by downregulating hypoxia-induced Met, Rac1, HIF-1α and VEGF expression in cocultured retinal pigment epithelial cells.
Du S; Wang S; Wu Q; Hu J; Li T
Exp Eye Res; 2013 Nov; 116():151-60. PubMed ID: 24016866
[TBL] [Abstract][Full Text] [Related]
14. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.
Amin EM; Oltean S; Hua J; Gammons MV; Hamdollah-Zadeh M; Welsh GI; Cheung MK; Ni L; Kase S; Rennel ES; Symonds KE; Nowak DG; Royer-Pokora B; Saleem MA; Hagiwara M; Schumacher VA; Harper SJ; Hinton DR; Bates DO; Ladomery MR
Cancer Cell; 2011 Dec; 20(6):768-80. PubMed ID: 22172722
[TBL] [Abstract][Full Text] [Related]
15. Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.
Jiang H; Wu M; Liu Y; Song L; Li S; Wang X; Zhang YF; Fang J; Wu S
J Neurochem; 2017 Nov; 143(3):375-388. PubMed ID: 28892569
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization.
Dong Z; Noda K; Kanda A; Fukuhara J; Ando R; Murata M; Saito W; Hagiwara M; Ishida S
Mol Vis; 2013; 19():536-43. PubMed ID: 23559848
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.
Li Y; Liu X; Zhou T; Kelley MR; Edwards P; Gao H; Qiao X
Redox Biol; 2014; 2():485-94. PubMed ID: 24624338
[TBL] [Abstract][Full Text] [Related]
18. Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer.
Mavrou A; Brakspear K; Hamdollah-Zadeh M; Damodaran G; Babaei-Jadidi R; Oxley J; Gillatt DA; Ladomery MR; Harper SJ; Bates DO; Oltean S
Oncogene; 2015 Aug; 34(33):4311-9. PubMed ID: 25381816
[TBL] [Abstract][Full Text] [Related]
19. Serine-arginine-rich protein kinase-1 inhibition for the treatment of diabetic retinopathy.
Malhi NK; Allen CL; Stewart E; Horton KL; Riu F; Batson J; Amoaku W; Morris JC; Arkill KP; Bates DO
Am J Physiol Heart Circ Physiol; 2022 Jun; 322(6):H1014-H1027. PubMed ID: 35302878
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
